SFA Therapeutics YC Başvurusu

Summer 2021Active

SFA Therapeutics, Healthcare şirketi olarak Summer 2021 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.

YC grubu: Summer 2021
Sektör: HealthcareTherapeutics
Ekip büyüklüğü: 4
Durum: Active
Lansmanı Yapıldı: 2021

Kurucular

Ira SpectorFounder
Alla ArzumanyanFounder
Mark FeitelsonFounder

SFA Therapeutics ne yapar

SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.

SFA Therapeutics'in YC başvurusu, yeniden yapılandırılmış

Y Combinator başvurusu

SFA Therapeutics, Summer 2021 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

SFA Therapeutics

Describe what your company does in 50 characters or less.

Regulating the immune system to block cancer & autoimmune diseases

What is your company going to make? Please describe your product and what it does or will do.

We are developing orally-administered immunoregulators targeting chronic inflammation that drives autoimmune diseases and certain cancers. Our drugs block key immune pathways causing diseases like psoriasis, pancreatic cancer, uveitis, and NASH. We already have strong phase 1b clinical data for psoriasis and a pipeline of 9 drug candidates with 15 patents.

Where do you live now, and where would the company be based after YC?

We live and are based in Philadelphia, PA, USA. After YC, we plan to stay in Philadelphia to leverage local biotech resources and keep our team intact.

Explain your decision regarding location.

Philadelphia is where our founders are based and where we've built our scientific and clinical collaborations. It has a strong biotech community and is well suited for therapeutic development, so relocating after YC is unnecessary.

Tam başvuruda 21 ek cevap

Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.

Tüm başvuruyu gör

Sıkça Sorulan Sorular

Bu, SFA Therapeutics şirketinin gerçek YC başvurusu mu?

Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, SFA Therapeutics'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. SFA Therapeutics gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.